Immune response may vary with choice of COVID-19 booster
Oropharyngeal cancer incidence and mortality rising in nearly all 50 states, reports new national study
16 December 2021Omicron is dominant in wastewater samples in Florida county
16 December 2021Immune response may vary with choice of COVID-19 booster
(HealthDay)—Immune response may vary with the choice of COVID-19 vaccine used for a third dose or booster following two doses of ChAdOx1 nCoV-19 (ChAd) or Pfizer BioNTech BNT162b2 (BNT), according to a study published online Dec. 2 in The Lancet.
